# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sigmund Freud (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET005-SYN
- Date: 2026-06-15
- Fictional facility: St. Posthumous Health Center
- Fictional author: Anton Reinholt, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Two-week review, seen the same day by maxillofacial prosthodontics. **S**

## History of present illness

Mr. Freud returns two weeks after intake and is seen by Dr. Vasquez-Lindqvist of maxillofacial prosthodontics on the same day. He finished the varenicline starter week and has taken 1 mg twice daily for a week. He has mild nausea when he takes it before breakfast and vivid dreams, and no change in mood. He now smokes about fourteen cigars a day, from twenty, and says the cigars are less satisfying. He is not yet ready to name a quit date but thinks it may be possible within a month. He has not called the quitline. His pain is unchanged at 6 of 10 on acetaminophen 1,000 mg three times daily. Liquids still leak into his nose at times. **S**

| Element | Detail |
|---|---|
| Cigars | About fourteen a day, from twenty |
| Varenicline | 1 mg twice daily for one week; mild nausea before breakfast; vivid dreams |
| Readiness | Considering a quit date within a month |
| Pain | 6 of 10 before today's reline |
| Weight | 58.2 kg |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; weight stable |
| Ears, nose, mouth, and throat | Positive | Sore spot at the front edge of the defect; nasal leakage of liquids; no bleeding or lump |
| Gastrointestinal | Positive | Mild nausea after the morning dose on an empty stomach |
| Psychiatric | Negative | Vivid dreams; mood steady; no agitation |

4 systems reviewed. **S**

## Current medications

- Varenicline 1 mg oral tablet, one tablet twice daily after food; planned for at least 24 weeks **S**
- Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain at the maxillectomy site **S**

## Allergies

- No known allergy **S**

## Objective

BP 136/80 mmHg; pulse 78 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 95% on room air; weight 58.2 kg; BMI 19.7 kg/m². All vital signs are synthetic.

Pain score (0 to 10): 6. All results are synthetic.

## Change since baseline

- Pain score (0 to 10): 6 at baseline, 6 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 136/80, pulse 78; weight 58.2 kg |
| Mouth | With the obturator out: 4 mm shallow ulcer with a clean base at the anterior margin of the defect where the flange presses; no induration, mass, white or red patch elsewhere |
| Neck | No lymph nodes felt |
| Respiratory | Clear to auscultation |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Tobacco use disorder, severe, on varenicline** (F17.290). Down by about a third in two weeks on varenicline, before setting a quit date, which is the approach the ATS guideline supports. The nausea is mild and should ease if he takes it after food. **S**
   - Continue varenicline 1 mg twice daily after food.
   - Keep cutting down; choose a quit date at the next visit.
   - Enrolled with the quitline during the visit by the clinic's tobacco treatment nurse.
2. **Maxillectomy defect with a worn obturator** (Z90.09). Dr. Vasquez-Lindqvist found a worn, porous obturator that no longer seals at the back and a pressure ulcer at the front. She relined it at the chair today and relieved the flange; a new definitive obturator is planned. The ulcer looks traumatic and should heal within two weeks once the pressure is relieved. **S**
   - Ulcer rechecked in two weeks at the prosthodontics clinic; head and neck surgeon and biopsy if it has not healed.
   - Impressions for the new obturator in about four weeks.
3. **Chronic pain at the maxillectomy site** (G89.29). Pain 6 of 10, mostly where the flange presses. **S**
   - Continue acetaminophen 1,000 mg three times daily.
   - Warm saline rinses after meals.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Tobacco use (cigars a day), readiness and quit date | Every visit | Completed today | About fourteen cigars a day, from twenty; quit date not yet chosen |
| Medication safety | Varenicline adherence and side effects (nausea, sleep, dreams, mood) | Every visit; at least 12 weeks, extended to 24 weeks or more | Completed today | 1 mg twice daily; mild nausea before breakfast, vivid dreams; no mood change; advised to take after food |
| Self-management | Behavioral support (quitline and clinic sessions) | Weekly calls around the quit date, then every two to four weeks | Deferred | He had not called the quitline in the two weeks since intake. No harm so far: he has cut down by a third. Corrective action: the tobacco treatment nurse enrolled him directly during the visit, and the quitline will call him this week |
| Laboratory | Kidney function for varenicline dosing | Baseline; again if illness or new medicines | Up to date | Creatinine 0.96 mg/dL, eGFR 83 at intake; no dose change needed |
| Examination | Head and neck surveillance examination (mouth, defect and neck) | Yearly by his head and neck surgeon more than five years after treatment; mouth checked at each visit | Completed today | Traumatic ulcer at the defect margin; no mass, induration or white or red patch; neck clear. Yearly surgeon's examination due in about two months |
| Imaging | Head and neck imaging | Only for symptoms or signs more than five years after treatment | Not indicated | Seven years after treatment with no symptoms of recurrence |
| Examination | Obturator fit, seal and hygiene | Every visit | Completed today | Worn, porous obturator with a poor posterior seal; relined and adjusted today by Dr. Vasquez-Lindqvist; new definitive obturator planned |
| Examination | Speech and swallowing (hypernasality, nasal leakage) | Every visit; speech-language therapy as needed | Completed today | Hypernasal speech and nasal leakage before the reline; better with the relined obturator; speech-language therapy planned |
| Self-management | Dental care (high-fluoride toothpaste, cleaning every three months) | Daily toothpaste; cleaning every three months | Completed today | High-fluoride toothpaste advised by Dr. Vasquez-Lindqvist |
| Examination | Osteoradionecrosis, trismus and neck fibrosis | Only after radiation to the head and neck | Not indicated | No radiation in his treatment |
| Laboratory | Thyroid function | Only after radiation to the neck | Not indicated | No neck radiation |
| Examination | Weight and nutrition | Every visit | Completed today | 58.2 kg; soft high-protein diet and supplements twice daily |
| Survey | Pain score and function | Every visit | Completed today | 6 of 10 before the reline |
| Medication safety | Acetaminophen daily dose (no more than 3,000 mg) | Every visit | Completed today | 3,000 mg a day; no other acetaminophen products |
| Medication safety | Opioids | Avoid long-term opioids | Not indicated | Not needed; pain is mechanical and improving with prosthetic care |
| Referral | Maxillofacial prosthodontics consultation | At a worn or poorly sealing obturator | Completed today | Seen by Dr. Vasquez-Lindqvist today |

## Goal progress

- Stop smoking cigars completely, at a pace he chooses, using varenicline and nicotine replacement. In progress; target 2026-10-26. **S**
- An obturator that seals and does not rub, so that speech is clear and liquids do not leak into his nose. In progress; target 2026-08-24. **S**
- Pain at 3 of 10 or less without opioids. In progress; target 2026-10-26. **S**
- Regain weight to at least 60 kg with a normal albumin. In progress; target 2026-10-26. **S**

## Guideline basis

- Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline (2020), American Thoracic Society (Am J Respir Crit Care Med 2020;202(2):e5-e31)
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force
- NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026), National Comprehensive Cancer Network
- American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016), American Cancer Society (CA Cancer J Clin 2016;66(3):203-239)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)

## Follow-up

- Quitline call this week. Six-week review in four weeks. Prosthodontic impressions for the new obturator in about four weeks. **S**
- Next scheduled visit 2026-07-13: six-week review: smoking down by two thirds, setting a quit date, pain and weight. **S**
